The lawsuit alleges that the drug companies (Novo Nordisk and Eli Lilly) knew their medications could cause stomach paralysis and failed to include that information on the warning label
doi: 10.1530/EDM-19-0150
"Therefore, compounded drugs should only be used to meet a patient's needs if they cannot be met by an available FDA-approved drug," the agency concluded
If you want to understand how your genetics influence your response to tirzepatide and other peptide therapies, the PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 pathways and 150+ genetic insights, including variants in GLP1R and GIPR genes that shape your medication effectiveness
Share: Popular GLP-1 drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have already transformed the treatment of type 2 diabetes and obesity
The option of once-a-month therapy may be attractive, if adequate efficacy is demonstrated